Holidayhill said...
My post RALP report also indicated the presence of perineural invasion. I wonder about the chance of having the cancer spreading outside the prostate and any increase in mortality risk? Although my 4.5 month post op PSA was great at <0.01, I am concerned this will not continue longer term. I have a scheduled meeting with urology on Thursday and will discuss.
Hi HH. What were the details of your post-op path report.
Your final path details are much more important than your biopsy details and should be in your signature. Did it confirm your G7 (4+3) and was the
only finding PNI? Perineural invasion is more important when seen in at
biopsy, since it correlates with negative findings at the time of surgery. Estimates for finding PNI
somewhere in the whole prostate after surgery run as high as >80% of men! It's significance is still debated, but I would not worry about
it if it's the only negative path finding! You post-treatment PSA of <0.01 is a good predictor of avoiding BCR in your future. Of course, nothing is certain in this game.
The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional Study (2019, Full Text)
"Methods and materials
We identified 1549 patients who received a diagnosis of margin-negative pT2N0M0 prostate cancer at 3 separate institutions between January 1, 2008 and December 31, 2014. We reviewed the electronic medical records of these patients and collected clinical and histologic data. A multivariable analysis was performed to assess the association between PNI and biochemical recurrence.
Results
Of the 1549 patients identified, 936 (60.4%) had PNI and 96 (6.2%) had biochemical recurrence. The median time until recurrence was 16 months.
...
Conclusions
We found that PNI was not an independent indicator of the risk of biochemical recurrence. Instead, PNI may be an indicator of unfavorable histology such as a high Gleason score or diffuse disease within the prostate in pT2N0 patients."
[Emphasis mine]
Djin